{
  "id": 666432,
  "title": "UCB’s pipeline strategy in 2026: Doubling down on immunology and neurology",
  "url": "https://urgent.news/2026/08/12/ucbs-pipeline-strategy-in-2026-doubling-down-on-immunology-and",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-08-12T13:00:00.000Z",
  "source": {
    "name": "Labiotech",
    "slug": "labiotech",
    "url": "https://www.labiotech.eu/top-pharma-strategy/ucb-pipeline-strategy/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Discover how UCB’s pipeline strategy in 2026 is still focused on its core areas of immunology and neurology. The post UCB’s pipeline strategy in 2026: Doubling down on immunology and neurology appeared first on Labiotech.eu . © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}